Candidemia in Acute Leukemia Patients

• Author(s): Ribeiro, P ; Sousa, AB ; Aveiro, F ; Nunes, O ; Fernandes, JP ; Gouveia, J
• Date: 1997
• Persistent ID: http://hdl.handle.net/10400.17/225
• Origin: Repositório do Centro Hospitalar de Lisboa Central, EPE
• Subject(s): Doença Aguda; Adulto; Candidíase; Causalidade; Fungemia; Hospedeiro Imunocomprometido; Incidência; Leucemia; Estudos Retrospectivos; Factores de Risco
• Document Type: Article
• Language: English

Description

Fungal infections are an important cause of morbidity and mortality in patients with acute leukemia (AL). Candidemia, once rare, is now a common nosocomial infection because of the intensity of chemotherapy, prolonged neutropenia, administration of broad-spectrum antibiotics and use of central venous catheters (CVC). We retrospectively identified patients treated for AL from 6/86 to 6/95 who also had candidemia. We describe 28 patients (incidence 6.3%) with a median age of 39 years, 24 of whom were on remission induction and 4 on postremission chemotherapy. All patients had CVC and empiric antimicrobial therapy, 4 had been given prophylactic antifungal drugs, and 2 had parenteral nutrition. Neutropenia was profound (median leukocyte nadir 200/microliters, median duration 19 days). Candida was isolated in blood cultures 10 days (median) after the start of neutropenia. The clinical presentation included fever (100%), respiratory symptoms (71.4%), skin lesions (39.2%) and septic shock (17.8%). Amphotericin B was given to 17 patients and liposomal amphotericin to 5 patients. Infection resolved in 18 patients (64.2%). 10 of whom were in complete remission. Mortality from candidemia was 17.8% (5/28). In conclusion, fungal infections are responsible for death in a significant number of patients. In our series treatment success was related to its rapid onset and to the recovery of neutropenia.